Wordt geladen...
Pharmacokinetics in Animals and Humans of a First-in-Class Peptide Deformylase Inhibitor
BB-83698, a potent and selective inhibitor of peptide deformylase, was the first compound of this novel antibacterial class to progress to clinical trials. Single- and/or multiple-dose studies with doses ranging from 10 to 50 mg of BB-83698/kg of body weight were done with mice, rats, and dogs. Intr...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Microbiology
2004
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC529202/ https://ncbi.nlm.nih.gov/pubmed/15561864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.12.4835-4842.2004 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|